FDA NDC Directory · JSON-LD · Markdown

Fulvestrant

NDC 63323-715 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerFresenius Kabi USA, LLC
Marketing categoryNew Drug Application (innovator) · App NDA210326
Dosage form / routeINJECTION, SOLUTION · INTRAMUSCULAR
Active ingredientsFULVESTRANT (50 mg/mL)
Marketing started20190520
Package count1

External sources

Source: openFDA. Public-domain (CC0).